TipRanks
Oncoclinicas do Brasil Servicos Medicos SA (BR:ONCO3)
:ONCO3
Brazil Market
ONCO3
Oncoclinicas do Brasil Servicos Medicos SA
RESEARCH TOOLSreports

Oncoclinicas do Brasil Servicos Medicos SA (ONCO3) Ratios

― Followers

Oncoclinicas do Brasil Servicos Medicos SA Ratios

BR:ONCO3's free cash flow for Q2 2026 was R$0.22. For the 2026 fiscal year, BR:ONCO3's free cash flow was decreased by R$ and operating cash flow was R$-0.08. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.44 0.56 1.90 1.71 1.50
Quick Ratio
 0.41 0.52 1.81 1.60 1.41
Cash Ratio
 0.02 0.10 0.22 0.30 0.14
Solvency Ratio
 -0.60 -0.55 -0.04 0.07 0.04
Operating Cash Flow Ratio
 0.05 -0.02 -0.08 -0.03 -0.14
Short-Term Operating Cash Flow Coverage
 0.09 -0.04 -0.24 -0.13 -0.80
Net Current Asset Value
R$ -3.89BR$ -3.17BR$ -3.16BR$ -3.40BR$ -2.76B
Leverage Ratios
Debt-to-Assets Ratio
 0.58 0.53 0.49 0.50 0.42
Debt-to-Equity Ratio
 231.94 4.22 1.74 1.98 1.64
Debt-to-Capital Ratio
 1.00 0.81 0.64 0.66 0.62
Long-Term Debt-to-Capital Ratio
 0.00 0.11 0.57 0.62 0.57
Financial Leverage Ratio
 401.31 7.91 3.56 3.99 3.88
Debt Service Coverage Ratio
 -0.74 -0.72 0.16 1.17 0.89
Interest Coverage Ratio
 -4.52 -3.88 -0.20 1.35 1.09
Debt to Market Cap
 3.04 1.80 3.41 0.63 1.12
Interest Debt Per Share
 6.78 6.58 9.86 9.77 8.14
Net Debt to EBITDA
 -1.45 -1.48 18.17 3.58 4.63
Profitability Margins
Gross Profit Margin
30.28%31.12%33.09%35.14%35.52%
EBIT Margin
-56.61%-44.02%-0.89%15.71%12.67%
EBITDA Margin
-50.72%-38.84%4.36%20.40%16.96%
Operating Profit Margin
-55.05%-42.98%-1.93%13.81%11.51%
Pretax Profit Margin
-77.35%-55.10%-10.55%5.51%2.97%
Net Profit Margin
-83.55%-63.14%-10.38%4.07%1.13%
Continuous Operations Profit Margin
-86.39%-63.96%-11.52%5.69%2.78%
Net Income Per EBT
108.01%114.58%98.38%73.92%38.06%
EBT Per EBIT
140.51%128.22%547.62%39.91%25.83%
Return on Assets (ROA)
-63.13%-50.82%-5.77%2.44%0.56%
Return on Equity (ROE)
-688.61%-402.23%-20.54%9.72%2.18%
Return on Capital Employed (ROCE)
-385.97%-127.89%-1.37%10.29%7.43%
Return on Invested Capital (ROIC)
-66.18%-47.87%-1.25%9.67%6.54%
Return on Tangible Assets
-104.12%-81.47%-8.67%4.48%1.07%
Earnings Yield
-632.88%-198.38%-44.80%3.42%1.67%
Efficiency Ratios
Receivables Turnover
 2.89 3.85 3.04 2.96 2.96
Payables Turnover
 2.44 3.60 4.09 4.48 4.36
Inventory Turnover
 16.97 21.31 18.50 17.25 16.08
Fixed Asset Turnover
 5.06 5.21 4.66 4.44 3.75
Asset Turnover
 0.76 0.80 0.56 0.60 0.50
Working Capital Turnover Ratio
 -1.62 -116.97 3.56 4.92 3.12
Cash Conversion Cycle
 -2.08 10.58 50.52 63.12 62.13
Days of Sales Outstanding
 126.12 94.76 120.10 123.50 123.17
Days of Inventory Outstanding
 21.51 17.13 19.73 21.16 22.70
Days of Payables Outstanding
 149.72 101.30 89.31 81.55 83.74
Operating Cycle
 147.64 111.88 139.83 144.66 145.87
Cash Flow Ratios
Operating Cash Flow Per Share
 0.48 -0.18 -0.30 -0.10 -0.57
Free Cash Flow Per Share
 0.28 -0.43 -0.65 -0.69 -1.19
CapEx Per Share
 0.20 0.25 0.35 0.60 0.63
Free Cash Flow to Operating Cash Flow
 0.58 2.42 2.16 7.04 2.11
Dividend Paid and CapEx Coverage Ratio
 1.95 -0.58 -0.82 -0.14 -0.85
Capital Expenditure Coverage Ratio
 2.39 -0.71 -0.86 -0.17 -0.90
Operating Cash Flow Coverage Ratio
 0.08 -0.03 -0.03 -0.01 -0.08
Operating Cash Flow to Sales Ratio
 0.06 -0.02 -0.03 >-0.01 -0.07
Free Cash Flow Yield
16.24%-15.70%-27.67%-5.55%-20.58%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.17 -0.50 -2.23 29.27 60.06
Price-to-Sales (P/S) Ratio
 0.23 0.32 0.23 1.19 0.68
Price-to-Book (P/B) Ratio
 40.03 2.03 0.46 2.84 1.31
Price-to-Free Cash Flow (P/FCF) Ratio
 6.16 -6.37 -3.61 -18.02 -4.86
Price-to-Operating Cash Flow Ratio
 2.09 -15.40 -7.80 -126.95 -10.23
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 <0.01 0.08 -0.30
Price-to-Fair Value
 40.03 2.03 0.46 2.84 1.31
Enterprise Value Multiple
 -1.90 -2.30 23.48 9.42 8.64
Enterprise Value
 4.80B 5.12B 6.37B 10.55B 5.99B
EV to EBITDA
 -1.90 -2.30 23.48 9.42 8.64
EV to Sales
 0.96 0.89 1.02 1.92 1.46
EV to Free Cash Flow
 26.15 -17.84 -15.96 -29.04 -10.47
EV to Operating Cash Flow
 15.22 -43.13 -34.46 -204.61 -22.05
Tangible Book Value Per Share
 -3.84 -2.40 -0.60 -2.89 -2.67
Shareholders’ Equity Per Share
 0.03 1.34 5.10 4.39 4.41
Tax and Other Ratios
Effective Tax Rate
 -0.12 -0.16 -0.09 -0.03 0.06
Revenue Per Share
 7.65 8.51 10.10 10.48 8.52
Net Income Per Share
 -6.39 -5.38 -1.05 0.43 0.10
Tax Burden
 1.08 1.15 0.98 0.74 0.38
Interest Burden
 1.37 1.25 11.91 0.35 0.23
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.26 0.24 0.22 0.21 0.24
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 -0.07 0.03 0.26 -0.23 -2.39
Currency in BRL